Haug U - Search Results

1

Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia.

Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H. Haug U, et al. Br J Cancer. 2011 May 24;104(11):1779-85. doi: 10.1038/bjc.2011.160. Epub 2011 May 10. Br J Cancer. 2011. PMID: 21559011 Free PMC article.

2

Use of Acitretin Among Girls and Women of Childbearing Age and Occurrence of Acitretin-Exposed Pregnancies in Germany.

Reinold J, Kollhorst B, Temme HL, Wentzell N, Haug U. Reinold J, et al. Among authors: haug u. Clin Drug Investig. 2023 Nov;43(11):865-872. doi: 10.1007/s40261-023-01314-2. Epub 2023 Oct 31. Clin Drug Investig. 2023. PMID: 37906397 Free PMC article.

3

Use of Methotrexate in Girls and Women of Childbearing Age, Occurrence of Methotrexate-Exposed Pregnancies and Their Outcomes in Germany: A Claims Data Analysis.

Wentzell N, Kollhorst B, Reinold J, Haug U. Wentzell N, et al. Among authors: haug u. Clin Drug Investig. 2023 Feb;43(2):109-117. doi: 10.1007/s40261-022-01227-6. Epub 2022 Dec 21. Clin Drug Investig. 2023. PMID: 36542272 Free PMC article.

4

Mild COVID-19 infection associated with post-COVID-19 condition after 3 months - a questionnaire survey.

Rach S, Kühne L, Zeeb H, Ahrens W, Haug U, Pohlabeln H. Rach S, et al. Among authors: haug u. Ann Med. 2023 Dec;55(1):2226907. doi: 10.1080/07853890.2023.2226907. Ann Med. 2023. PMID: 37337723 Free PMC article.

5

Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida.

Haug U, Kollhorst B, Schink T, Thöne K, Dathe K, Schaefer C, Onken M. Haug U, et al. Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):148-157. doi: 10.1002/pds.5573. Epub 2022 Nov 30. Pharmacoepidemiol Drug Saf. 2023. PMID: 36401747

6

A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy.

Haug U, Brenner H. Haug U, et al. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):422-8. doi: 10.1158/1055-9965.EPI-04-0411. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734968

7

New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness.

Haug U, Brenner H. Haug U, et al. Int J Cancer. 2005 Nov 1;117(2):169-76. doi: 10.1002/ijc.21016. Int J Cancer. 2005. PMID: 15880368

8

Tumor M2 pyruvate kinase as a stool marker for colorectal cancer: stability at room temperature and implications for application in the screening setting.

Haug U, Wente MN, Seiler CM, Rothenbacher D, Büchler MW, Brenner H. Haug U, et al. Clin Chem. 2006 Apr;52(4):782-4. doi: 10.1373/clinchem.2005.062752. Clin Chem. 2006. PMID: 16595841 No abstract available.

9

Gender differences in colorectal cancer: implications for age at initiation of screening.

Brenner H, Hoffmeister M, Arndt V, Haug U. Brenner H, et al. Among authors: haug u. Br J Cancer. 2007 Mar 12;96(5):828-31. doi: 10.1038/sj.bjc.6603628. Epub 2007 Feb 20. Br J Cancer. 2007. PMID: 17311019 Free PMC article.

10

Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.

Haug U, Hillebrand T, Bendzko P, Löw M, Rothenbacher D, Stegmaier C, Brenner H. Haug U, et al. Clin Chem. 2007 Apr;53(4):787-90. doi: 10.1373/clinchem.2006.078188. Epub 2007 Feb 22. Clin Chem. 2007. PMID: 17317884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters